BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 7 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2022. The put-call ratio across all filers is 3.11 and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $43,509,000 | +56.3% | 287,812 | +50.7% | 0.04% | +65.2% |
| Q2 2022 | $27,835,000 | -65.7% | 191,031 | -72.1% | 0.02% | -58.9% |
| Q1 2022 | $81,201,000 | +209.2% | 684,834 | +259.4% | 0.06% | +229.4% |
| Q4 2021 | $26,261,000 | -32.2% | 190,559 | -31.6% | 0.02% | -37.0% |
| Q3 2021 | $38,725,000 | +112.5% | 278,776 | +48.5% | 0.03% | +125.0% |
| Q2 2021 | $18,224,000 | +43.3% | 187,725 | +0.9% | 0.01% | +33.3% |
| Q1 2021 | $12,715,000 | -21.4% | 186,029 | -1.4% | 0.01% | -30.8% |
| Q4 2020 | $16,170,000 | +39.7% | 188,658 | +5.9% | 0.01% | +30.0% |
| Q3 2020 | $11,576,000 | +5.4% | 178,067 | +18.5% | 0.01% | 0.0% |
| Q2 2020 | $10,985,000 | +325.9% | 150,256 | +98.3% | 0.01% | +233.3% |
| Q1 2020 | $2,579,000 | +67.0% | 75,790 | +32.5% | 0.00% | +50.0% |
| Q4 2017 | $1,544,000 | +12.3% | 57,216 | +55.6% | 0.00% | +100.0% |
| Q3 2017 | $1,375,000 | -2.5% | 36,772 | -34.8% | 0.00% | 0.0% |
| Q2 2017 | $1,410,000 | – | 56,390 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
| RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
| JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
| Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
| Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
| FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 3,784,482 | $572,100,000,000 | 10.85% |
| Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
| EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
| HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |